Sleeping sickness and the brain

被引:42
作者
Enanga, B [1 ]
Burchmore, RJS [1 ]
Stewart, ML [1 ]
Barrett, MP [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
关键词
sleeping sickness; central nervous system; blood brain barrier; trypanosome; chemotherapy;
D O I
10.1007/s00018-002-8472-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent progress in understanding the neuropathological mechanisms of sleeping sickness reveals a complex relationship between the trypanosome parasite that causes this disease and the host nervous system. The pathology of late-stage sleeping sickness, in which the central nervous system is involved, is complicated and is associated with disturbances in the circadian rhythm of sleep. The blood-brain barrier, which separates circulating blood from the central nervous system, regulates the flow of materials to and from the brain. During the course of disease, the integrity of the blood-brain barrier is compromised. Dysfunction of the nervous system may be exacerbated by factors of trypanosomal origin or by host responses to parasites. Microscopic examination of cerebrospinal fluid remains the best way to confirm late-stage sleeping sickness, but this necessitates a risky lumbar puncture. Most drugs, including many trypanocides, do not cross the blood-brain barrier efficiently. Improved diagnostic and therapeutic approaches are thus urgently required. The latter might benefit from approaches which manipulate the blood-brain barrier to enhance permeability or to limit drug efflux. This review summarizes our current understanding of the neurological aspects of sleeping sickness, and envisages new research into blood-brain barrier models that are necessary to understand the interactions between trypanosomes and drugs active against them within the host nervous system.
引用
收藏
页码:845 / 858
页数:14
相关论文
共 137 条
[51]  
Enanga B, 2000, ARZNEIMITTEL-FORSCH, V50, P158
[52]   Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice [J].
Enanga, B ;
Keita, M ;
Chauviere, G ;
Dumas, M ;
Bouteille, B .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1998, 3 (09) :736-741
[53]  
Enanga B, 1999, ARZNEIMITTEL-FORSCH, V49, P441
[54]   BIDIRECTIONAL SIGNALS BETWEEN TRYPANOSOMA-BRUCEI-BRUCEI AND DORSAL-ROOT GANGLION NEURONS [J].
ENEROTH, A ;
BAKHIET, M ;
OLSSON, T ;
KRISTENSSON, K .
JOURNAL OF NEUROCYTOLOGY, 1992, 21 (12) :846-852
[55]   ADHESION MOLECULES ON MURINE BRAIN MICROVASCULAR ENDOTHELIAL-CELLS - EXPRESSION AND REGULATION OF ICAM-1 AND LGP-55 [J].
FABRY, Z ;
WALDSCHMIDT, MM ;
HENDRICKSON, D ;
KEINER, J ;
LOVEHOMAN, L ;
TAKEI, F ;
HART, MN .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (01) :1-11
[56]  
FEINSTEIN DL, 1994, J NEUROCHEM, V62, P315
[57]  
FERREIRA R C C, 1986, Memorias do Instituto Oswaldo Cruz, V81, P49, DOI 10.1590/S0074-02761986000100006
[58]  
FRIEDHEIM EAH, 1949, AM J TROP MED, V29, P173
[59]   Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes [J].
Gaillard, PJ ;
Voorwinden, LH ;
Nielsen, JL ;
Ivanov, A ;
Atsumi, R ;
Engman, H ;
Ringbom, C ;
de Boer, AG ;
Breimer, DD .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 12 (03) :215-222
[60]  
Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45